Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Talis Biomedical Corp (TLIS)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
   10-K10-K10-K10-KS-1/A
Net income  -113.0-192.0-91.126.4-21.3
Depreciation and amortization  8.81.60.80.70.6
Asset impairment charges  3.6    
Stock-based compensation  5.49.2 1.00.7
Change in working capital   [+]-8.42.47.30.31.0
Other operating activities  3.57.4-3.9-52.7-1.9
Cash from operations  -100.1-171.4-87.0-24.3-20.9
   
Capital expenditures  -1.6-2.98.2-0.6-0.5
Other cash from investing    -16.4  
Cash from investing  -1.6-2.9-8.2-0.6-0.5
   
Issuance of common stock, net   232.5   
Option exercises  0.41.40.0  
Other cash from financing  0.83.3246.839.60.0
Cash from financing  0.4234.4246.839.60.0
   
Free cash flow  -101.8-174.3-78.8-24.9-21.5
        Per share (diluted)  ($3.82)($7.69)($37.18)($11.58)($40.89)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy